Centrifugation-free Sperm Separation Systems market growth at a CAGR of ~ 4.7% from 2021 to 2027
The global Centrifugation-free Sperm Separation Systems market gathered revenue around USD 104 Million in 2020 and market is set to grow USD 195 Million by the end of 2027 and is estimated to expand at a modest CAGR of 4.7% during the prediction period 2021 to 2027. Sperm separation is a technique that separates sperm cells within a semen sample according to the sex chromosome contained in a sperm cell. The separated sperm samples can then be used for artificial insemination or the process of injecting sperm directly into a female's uterus for fertilization. Centrifugation-free sperm separation is a technique used for sperm separation, as it prevents sperm damage. Different types of technique used for centrifugation-free sperm separation are migration-sedimentation (MS), microfluidic sperm sorters (MFSSs), and others. The global centrifugation-free sperm separation systems market is driven by increase in incidence of infertility in men and women and surge in number of IVF centers across the globe.
North America dominated the global centrifugation-free sperm separation systems market in 2020. The trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early adoption of new products, high prevalence rate of infertility, and presence of major players are expected to propel the centrifugation-free sperm separation systems market in North America. Asia Pacific is likely to be a highly lucrative market for centrifugation-free sperm separation systems during the forecast period. The market in the region is projected to expand at a high CAGR from 2021 to 2027.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Centrifugation-free Sperm Separation Systems market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Centrifugation-free Sperm Separation Systems market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Centrifugation-free Sperm Separation Systems market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Hospitals & Clinics Held Major Market Share
In terms of end user, the global centrifugation-free sperm separation systems market has been divided into hospitals & clinics, cryobanks, IVF centers, and others. The hospitals & clinics segment led the global centrifugation-free sperm separation systems market in terms of revenue in 2020. The trend is projected to continue during the forecast period. Hospitals are an important channel for in-vitro fertilization procedure. According to government healthcare facilities, hospitals have reimbursement plans and advanced technology systems for disease treatment. The expansion of the segment can be attributed to the increase in the number of hospital facilities across the world. The segment is also driven by increase in number of surgeries and hospital facilities across the world.
North America to Lead Centrifugation-free Sperm Separation Systems Market
In terms of region, the global centrifugation-free sperm separation systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global centrifugation-free sperm separation systems market in 2020, followed by Europe. North America’s large market share can be ascribed to increase in number of people with major infertility, new product launches, and presence of major players. The centrifugation-free sperm separation systems market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2027. This can be ascribed to the presence of developing countries with commercial hubs, expanding business organizations, rise in awareness about infertility, improving healthcare infrastructure, and increase in investments by companies.
| Report Highlights | Details |
| Market Size | US$ 195 Million by 2027 |
| Growth Rate | CAGR of 4.7% From 2021 to 2027 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2027 |
| Segments Covered | Technique,End User |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | CooperSurgical, Inc., Koek Biotechnology Bioengineering and Medical Services Industry & Trade, Inc., Memphasys Ltd., DxNow, SAR Healthline Pvt. Ltd., and Lotus Bio |
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Centrifugation-free Sperm Separation Systems Market are:
The global market include CooperSurgical, Inc., Koek Biotechnology Bioengineering and Medical Services Industry & Trade, Inc., Memphasys Ltd., DxNow, SAR Healthline Pvt. Ltd., and Lotus Bio.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Centrifugation-free Sperm Separation Systems Market: Segmentation
North America
Europe
Asia Pacific
Central & South America
Middle East and Africa
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Centrifugation-Free Sperm Separation Systems Market, By Technique
7.1. Centrifugation-Free Sperm Separation Systems Market, by Technique, 2021-2027
7.1.1. Migration-sedimentation (MS)
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Migration-sedimentation (MS)
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Others
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Centrifugation-Free Sperm Separation Systems Market, By End User
8.1. Centrifugation-Free Sperm Separation Systems Market, by End User, 2021-2027
8.1.1. Hospitals & Clinics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Cryobanks
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. IVF Centers
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Centrifugation-Free Sperm Separation Systems Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Technique (2016-2027)
9.1.2. Market Revenue and Forecast, by End User (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.1.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.1.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Technique (2016-2027)
9.2.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.2.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.2.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Technique (2016-2027)
9.2.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Technique (2016-2027)
9.2.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.3.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.3.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Technique (2016-2027)
9.3.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Technique (2016-2027)
9.3.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.4.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.4.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Technique (2016-2027)
9.4.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Technique (2016-2027)
9.4.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Technique (2016-2027)
9.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Technique (2016-2027)
9.5.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Technique (2016-2027)
9.5.4.2. Market Revenue and Forecast, by End User (2016-2027)
Chapter 10. Company Profiles
10.1. CooperSurgical, Inc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.1.5. Koek Biotechnology Bioengineering
10.1.6. Company Overview
10.1.7. Product Offerings
10.1.8. Financial Performance
10.1.9. Recent Initiatives
10.2. Medical Services Industry & Trade, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Memphasys Ltd.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. DxNow
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. SAR Healthline Pvt. Ltd.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Lotus Bio.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers